Boston Scientific (BSX) Net Equity Issued and Repurchased (2009 - 2020)

Boston Scientific has reported Net Equity Issued and Repurchased for 12 years, with the latest figure at $933.0 million in Q2 2020.

• Net Equity Issued and Repurchased for Q2 2020 came in at $933.0 million, up 1860.38% year-over-year; the trailing twelve-month figure through Sep 2021 was $933.0 million (down 4.31% YoY), and the FY2020 annual result was $975.0 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased grew to $933.0 million in Q2 2020, from $42.0 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $933.0 million in Q2 2020 and troughed at -$94.0 million in Q4 2018.
• A 5-year average of $73.2 million and a median of $34.0 million in 2016 frame the typical range for Net Equity Issued and Repurchased.
• The widest annual swing landed in 2018, when Net Equity Issued and Repurchased slumped 1666.67%; it then surged 1860.38% in 2020.
• A 5-year view of Net Equity Issued and Repurchased shows it stood at $3.0 million in 2016, then surged by 100.0% to $6.0 million in 2017, then slumped by 1666.67% to -$94.0 million in 2018, then surged by 43.62% to -$53.0 million in 2019, then surged by 1860.38% to $933.0 million in 2020.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $933.0 million in Q2 2020, $42.0 million in Q1 2020, and -$53.0 million in Q2 2019.